Primary FDA-Approved Indications
Preferred for giardiasis and trichomoniasis when single-dose therapy improves adherence.
Giardiasis
FDA ApprovedChildrenRandomized trials
Evidence Sources
()
Trichomoniasis
FDA ApprovedAdolescentsCDC STI guideline
Evidence Sources
()
Amebiasis
FDA ApprovedChildrenIDSA guideline